首页> 外文期刊>International Journal of Ayurvedic Medicine >Study of Karpoor Ghrita and Povidine Iodine in Sadyo Vrana
【24h】

Study of Karpoor Ghrita and Povidine Iodine in Sadyo Vrana

机译:Sadyo Vrana中的Karpur Ghrita和聚维酮碘的研究

获取原文
       

摘要

Aims: Study of local use of Karpoor ghrita and Povidone- Iodine in Sadyovrana. Objectives: 1.To study comparative effect of karpoor ghrita and Povidone- Iodine in sadyovrana. 2. To study assess the effect of ‘karpoor ghrita’ in minimizing infections after injury. 3. To study compare the days for wound healing for both drugs. As the reference has been quoted from Sadyo Vrana Chikitsadhyaya, the formulation of this medicine is to be used only in Sadyo Vranas i.e. Shuddha Vrana. Methods: In this study 60 Diagnosed Patients Of sadyovrana were Taken From O.P.D And I.P.D Of Shalyatantra Department Of hospital. Clinical was Conducted.Computer Generated Random Number Table Were Used For Clinical Trial. Trial group 30 Patients Of karpoor ghrita dressing and control group 30 patients of povidone- iodine dressing were Enrolled Under Following Groups Irrespective Of Sex And Religion. Observations and results: In this clinical study it is seen that, Clinical parameters like Vedana,, Varna, Akruti, Gandha, were significantly reduced after treatment in Trial group than in Control Group and srava showed equal results. Number of Days required for ropan were less in Trial group than that in Control Group. After testing the effectiveness of Karpoorghrita treatment against the Standard betadine Treatment, results showed that The Karpoorghrita treatment has better results than the Standard betadine in Sadyovrana Patients.
机译:目的:研究在萨迪奥夫拉纳(Sadyovrana)当地使用Karpoor ghrita和聚维酮碘的情况。目的:1.研究卡波氏菌和聚维酮-碘在萨迪ovrana中的比较效果。 2.研究评估“ karpoor ghrita”对减少受伤后感染的影响。 3.研究比较两种药物伤口愈合的天数。正如引用自Sadyo Vrana Chikitsadhyaya的参考文献一样,该药物的配方仅可用于Sadyo Vranas,即Shuddha Vrana。方法:在本研究中,从医院的Shalyatantra医院的O.P.D和I.P.D中提取了60例经诊断的Sadyovrana患者。进行临床试验。计算机生成的随机数表用于临床试验。试验组30例卡普尔妇女穿刺敷料患者和对照组30例聚维酮碘敷料患者入选以下各组,不论其性别和宗教信仰。观察结果:在该临床研究中,试验组治疗后的Vedana,Varna,Akruti,Gandha等临床参数与对照组相比明显降低,而srava的结果相同。试验组的ropan所需天数少于对照组。在测试了Karpoorghrita治疗相对于标准Betadine治疗的有效性后,结果表明,在Sadyovrana患者中,Karpoorghrita治疗比标准Betadine具有更好的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号